All times are listed in CEST (Central European Summer Time)

Displaying One Session

View
Controversy session

Are we ready to consider chemotherapy + checkpoint inhibitor as the preferred option in the neoadjuvant setting?

Date
Tue, 21.09.2021
Time
14:20 - 14:55
Location
Channel 6
Chairs
  • Nicolas Girard (Paris, France)
Controversy session

Introduction by the chair

Speakers
  • Nicolas Girard (Paris, France)
Lecture Time
14:20 - 14:23
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Tue, 21.09.2021
Time
14:20 - 14:55
Controversy session

Polling 1 (led by chair)

Lecture Time
14:23 - 14:24
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Tue, 21.09.2021
Time
14:20 - 14:55
Controversy session

Yes

Speakers
  • Heather Wakelee (Stanford, CA, United States of America)
Lecture Time
14:24 - 14:34
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Tue, 21.09.2021
Time
14:20 - 14:55
Controversy session

No

Speakers
  • Martin Reck (Grosshansdorf, Germany)
Lecture Time
14:34 - 14:44
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Tue, 21.09.2021
Time
14:20 - 14:55
Controversy session

Polling 2 (led by chair)

Speakers
  • Nicolas Girard (Paris, France)
Lecture Time
14:44 - 14:45
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Tue, 21.09.2021
Time
14:20 - 14:55
Controversy session

Q&A

Speakers
  • Nicolas Girard (Paris, France)
Lecture Time
14:45 - 14:55
Session Name
Controversy session
Location
Channel 6, Paris Expo Porte de Versailles, Paris, France
Date
Tue, 21.09.2021
Time
14:20 - 14:55